FDA Adverse Event Death Summary report: N

FORTIFY VR, U1.6 SJ4 ID

MDR report key: 5125355 · Received October 2, 2015

Report

Report Number
3010215456-2015-29298
Event Type
Death
Date Received
October 2, 2015
Date of Event
August 28, 2015
Report Date
September 7, 2015
Manufacturer
ST. JUDE MEDICAL, INC. (CRM-KISTA)
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS ADMITTED TO THE HOSPITAL AND WAS MONITORED DUE TO A SERIOUS CONDITION OF CARDIAC FAILURE, EXCESS POST-EXERCISE OXYGEN CONSUMPTION (EPOC) AND HIGH RISK FOR CATASTROPHIC DETERIORATION. IT WAS LATER REPORTED THAT THE PATIENT EXPIRED. UPON INTERROGATION OF THE DEVICE IT WAS NOTED THAT MULTIPLE SHOCKS WERE DELIVERED. THE PHYSICIAN STATED THE THERE IS SOME EVENT THAT WAS NOT SENSED ALTHOUGH, THE DEATH WAS NOT DUE TO THE DEVICE. REVIEW OF THE EPISODE REVEALED THAT, THE DEVICE IS WORKING IN ACCORDANCE HOW IT HAS BEEN PROGRAMMED. AS THEY HAVE PROGRAMMED A VT MONITORING ZONE BELOW PROGRAMMED VF ZONE, THE VF COUNTER IS RESET AT EACH VT RE-DIAGNOSIS, CONSEQUENTLY ON A NUMBER OF OCCASIONS VF DIAGNOSIS IS NOT REACHED BEFORE THE BIN IS EMPTIED AND VF BINNING HAS TO START OVER. THIS IS NORMAL DEVICE FUNCTION ACCORDING TO PROGRAMMED SETTINGS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
655460 FORTIFY VR, U1.6 SJ4 ID IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS ST. JUDE MEDICAL, INC. (CRM-KISTA) CD1233-40Q 3668051

Patients

Seq Age Sex Outcome Treatment
1 Death